CS Diagnostics Corp (FZRO)
0.156
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
CS Diagnostics 1 Year Total Returns (Daily): -91.33% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -91.33% |
May 02, 2024 | -93.22% |
May 01, 2024 | -95.20% |
April 30, 2024 | -95.69% |
April 29, 2024 | -95.69% |
April 26, 2024 | -95.69% |
April 25, 2024 | -95.69% |
April 24, 2024 | -95.69% |
April 23, 2024 | -95.69% |
April 22, 2024 | -95.69% |
April 19, 2024 | -90.25% |
April 18, 2024 | -90.25% |
April 17, 2024 | -95.69% |
April 16, 2024 | -95.25% |
April 15, 2024 | -95.25% |
April 12, 2024 | -91.75% |
April 11, 2024 | -91.75% |
April 10, 2024 | -89.85% |
April 09, 2024 | -89.23% |
April 08, 2024 | -94.70% |
April 05, 2024 | -94.70% |
April 04, 2024 | -94.70% |
April 03, 2024 | -94.70% |
April 02, 2024 | -87.69% |
April 01, 2024 | -95.08% |
Date | Value |
---|---|
March 28, 2024 | -95.20% |
March 27, 2024 | -92.62% |
March 26, 2024 | -92.73% |
March 25, 2024 | -92.73% |
March 22, 2024 | -92.73% |
March 21, 2024 | -90.80% |
March 20, 2024 | -90.66% |
March 19, 2024 | -88.00% |
March 18, 2024 | -88.00% |
March 15, 2024 | -87.69% |
March 14, 2024 | -93.23% |
March 13, 2024 | -87.43% |
March 12, 2024 | -87.43% |
March 11, 2024 | -88.57% |
March 08, 2024 | -77.14% |
March 07, 2024 | -87.43% |
March 06, 2024 | -93.85% |
March 05, 2024 | -95.02% |
March 04, 2024 | -95.02% |
March 01, 2024 | -86.15% |
February 29, 2024 | -88.62% |
February 28, 2024 | -88.62% |
February 27, 2024 | -88.62% |
February 26, 2024 | -88.62% |
February 23, 2024 | -91.42% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.53%
Minimum
Aug 08 2023
9.30K%
Maximum
Nov 17 2022
433.3%
Average
25.00%
Median
May 13 2019
1 Year Total Returns (Daily) Benchmarks
Advanced BioMedical Technologies Inc | -98.67% |
Global Wholehealth Partners Corp | -66.67% |
Perspective Therapeutics Inc | 196.0% |
Xtant Medical Holdings Inc | 41.62% |
Asensus Surgical Inc | -62.34% |